Comparison of rate of AAR between patients with low-dose reactivity and tolerance
The number of patients who experienced AAR was significantly higher in patients with low-dose reactivity than in those with low-dose tolerance in all cohorts (23.0% vs. 9.8%; p <0.001, Figure 2A). Furthermore, the same significant differences were observed for HE, CM, and peanut allergies, respectively (18.1% vs. 9.5%, 25.4% vs. 6.9%, and 16.3% vs. 2.2%; p = 0.009, <0.001, and 0.017, respectively; Figure 2B).